Richard Pazdur, a veteran regulator at the Food and Drug Administration who departed last month, said Monday at a STAT event that the firewall between political appointees and drug reviewers at the agency “has been breached,” and that there is not enough transparency around a new voucher program that grants accelerated review to certain drugs selected by Trump administration officials.